demonstrated that Fitm2, as a universal regulator in multiple types of cancer, increased tumor cell sensitivity to CTL-produced IFN-γ through increasing their susceptibility to oxidative proteotoxic and lipotoxic stress. The gene discussed is IFNG; the disease is neoplasm.